Aripiprazole and Opsumit drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aripiprazole (aripiprazole) and Opsumit (macitentan). Common drug interactions include dyspnoea among females.

The phase IV clinical study analyzes what interactions people have when they take Aripiprazole and Opsumit. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Aripiprazole?

Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.

What is Opsumit?

Opsumit has active ingredients of macitentan. eHealthMe is studying from 67,926 Opsumit users. Check the latest studies of Opsumit.



On Jul, 26, 2026

35 people who take Aripiprazole and Opsumit together, and have interactions are studied.

Aripiprazole and Opsumit drug interactions.

What are the common drug interactions of Aripiprazole and Opsumit, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Diarrhoea
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. Pyrexia (fever)
  5. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  6. Bacterial infection
  7. Catheter site haemorrhage (bleeding at catheter site)
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Device dislocation
  10. Feeling of despair

male:

n/a

What are the common drug interactions of Aripiprazole and Opsumit, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Diarrhoea
  2. Death
  3. Vomiting
  4. Catheter site discharge
  5. Catheter site infection (infection at the site of insertion)
  6. Colitis ulcerative (inflammation of colon with ulcer)
  7. Flushing (the warm, red condition of human skin)
  8. Headache (pain in head)
  9. Nausea (feeling of having an urge to vomit)
  10. Rash

30-39:

  1. Cataract (clouding of the lens inside the eye)
  2. Cellulitis (infection under the skin)
  3. Device related infection

40-49:

  1. Head discomfort
  2. Heart rate increased
  3. Hypertension (high blood pressure)
  4. Immunosuppression
  5. Inflammation
  6. Influenza
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Myalgia (muscle pain)
  9. Neuralgia (pain in one or more nerves)
  10. Oedema peripheral (superficial swelling)

50-59:

  1. Aspartate aminotransferase increased
  2. Blood alkaline phosphatase increased
  3. Blood bilirubin increased
  4. Fall
  5. Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Muscular weakness (muscle weakness)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Paralysis
  10. Asthenia (weakness)

60+:

  1. Cardiac failure congestive
  2. Dyspnoea (difficult or laboured respiration)
  3. Peripheral swelling
  4. Pneumonia
  5. Polyuria (production of too much dilute urine)
  6. Pyrexia (fever)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Fall
  9. Femoral neck fracture (neck of femur bone fracture)
  10. Hyperhidrosis (abnormally increased sweating)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 28 people, 80.00%
  2. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 3 people, 8.57%
  3. Nausea (feeling of having an urge to vomit): 3 people, 8.57%
  4. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 5.71%
  5. Nausea And Vomiting: 2 people, 5.71%
  6. Cough: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Aripiprazole and Opsumit?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aripiprazole and Opsumit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aripiprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Opsumit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aripiprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Opsumit and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and macitentan (the active ingredients of Aripiprazole and Opsumit, respectively), and Aripiprazole and Opsumit (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: